drugset / Trial / NCT01144650

Dapsone for Acute Ischemia Stroke Study

NCT01144650

RandomizedParallel-groupTriple-blindPrevention

Summary

The main purpose of the study is to get information about the safety and efficacy of treatment with Dapsone to prevent the disability after ischemic Stroke, in patients diagnosed with anterior territory brain infarct.

Timeline

Start
2009-07
Primary completion
2010-08
Completion
2010-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Dapsone Small molecule 250 mg Intravenous

Indications